Tirzepatide for alcoholism

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 29 May 2025: Trial registered, NCT06994338
  2. 6 Oct 2025: Trial started, NCT06994338

The trials

NCT06994338: Tirzepatide for Alcohol Use Disorder

State
Under way
Phase
Phase 2
People
42 planned
Started
6 Oct 2025
Primary completion
31 Aug 2026
Arms
Tirzepatide
Results
None posted
  1. 29 May 2025: Trial registered
  2. 6 Oct 2025: Trial started

NCT07292519: Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)

State
Not started
Phase
Phase 2
People
46 planned
Started
15 Jan 2026
Primary completion
15 May 2027
Arms
Tirzepatide: subcutaneous administration of Tirzepatide plus CBT ("Take Control" program)
Results
None posted
  1. 18 Dec 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Arm 5- Tirzepatide, Mounjaro, Tirzepatide (LIPOLESS de Laboratorio de Productos Eticos C.E.I.S.A.), Zepbound.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.